Health Condition 1: J454- Moderate persistent asthma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Children aged 6 years and 12 years old at time of giving consent 2. Children with symptoms of Wheezing, Cough, difficulty in breathing, Tightness of Chest as per IAP 2022 Asthma guidelines 3. History of wheezing more than three episodes in a year. 4. Patients having Spirometry values within ranges [FEV1] 5. Willing to sign consent and assent forms. 6. Patient willing to attend the OPD once in 7 days for 40 days.
Exclusion criteria
Exclusion criteria: 1. Any other lung disease other than Asthma. 2. Patients unable to perform Spirometry test. 3. Patients who are in the process of another clinical research. 4. Children with any other active systemic illnesses
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy of the trial drug is measured by Spirometry test (FEV1) on 0th,22th and 40th day treatment and improvement in the clinical condition will be determined through in this data. Changes in the clinical symptoms will be recorded by Asthma control Questionnaire at each visit (Once in 7 days) for 40 days. Timepoint: Pre-treatment, post-treatment (40 days), and follow-up (3 months). | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
National Institute of Siddha